Novartis Tavist ND Loratadine Tablets Carry Geneva’s Marketing Exclusivity
This article was originally published in The Tan Sheet
Executive Summary
Geneva Pharmaceuticals initially will market the first generic competition to Schering-Plough's OTC Claritin behind pharmacy counters
You may also be interested in...
Novartis Omeprazole Offering, Wellpoint, Prilosec OTC Pressure PPI Prices
Novartis' entrance into the OTC loratadine market in March could set a precedent for the firm to make a similar move with the proton pump inhibitor omeprazole
Novartis Omeprazole Offering, Wellpoint, Prilosec OTC Pressure PPI Prices
Novartis' entrance into the OTC loratadine market in March could set a precedent for the firm to make a similar move with the proton pump inhibitor omeprazole
Novartis Omeprazole Offering, Wellpoint, Prilosec OTC Pressure PPI Prices
Novartis' entrance into the OTC loratadine market in March could set a precedent for the firm to make a similar move with the proton pump inhibitor omeprazole